Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cardiovascular Diseases in Patients After Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis Publisher Pubmed



Alizadehasl A1 ; Ghadimi N1 ; Hosseinifard H2 ; Roudini K3 ; Emami AH4 ; Ghavamzadeh A5 ; Khodaamorzideh D1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center for evidence-based medicine (rcebm), Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Department of internal medicine, Hematology and Medical oncology ward, Cancer research center, cancer institute, Imam Khomeini hospital complex, Tehran University of medical sciences, Tehran, Iran
  4. 4. Department of internal Medicine, school of medicine cancer institute, Imam Khomeini Hospital Tehran University of Medical Sciences
  5. 5. Cancer & cell Therapy Research Center, Tehran University of medical Scinces Tehran

Source: Current Research in Translational Medicine Published:2023


Abstract

Background: Hematopoietic Stem Cell Transplantation (HSCT), is performed to treat many malignancies such as autologous or allogenic. Despite the success of this method in treating patients, - sometimes some HSCT recipients face problems such as cardiovascular complications. Therefore, this systematic review and meta-analysis aimed to evaluate the prevalence of cardiovascular complications in post-transplant patients. Method: In order to review the published studies, we examined PubMed, MEDLINE, Cochrane Library, Scopus, and web of science databases from the beginning to the end of January 2022, and we used tools by the Newcastle–Ottawa Scale to evaluate the quality of the studies. Result: In this study, 37 articles were included in the meta-analysis and 30,957 patients were examined. Also, the mean age of patients was 35.37 years. Based on the results of the meta-analysis, the prevalence of cardiovascular disease (CVD), was 16.84%. In addition, other complications related to CVD which include Arrhythmias, Congestive Heart Failure (CHF), Hypertension, stroke, and mortality were examined in patients who had hematopoietic stem cell transplantation and the resulting amounts were 3.91%, 3.66, 17.71, 0.22%, and 1.53%, respectively. Conclusion: This study showed that the prevalence of cardiovascular disease after hematopoietic stem cell transplantation is high and needs special attention. © 2022 Elsevier Masson SAS
Related Docs
1. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
2. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Peripheral Arterial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
4. Burden of Cardiovascular Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
5. Pericardial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
6. Long Term Cardiotoxicity Surveillance in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
7. Late Complications in Acute Leukemia Patients Following Hsct: A Single Center Experience, International Journal of Hematology-Oncology and Stem Cell Research (2016)
8. Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Vaezi (2)
Kamran Roudini (2)